SEBASTIANI, GUIDO
 Distribuzione geografica
Continente #
NA - Nord America 7.219
EU - Europa 5.503
AS - Asia 2.775
SA - Sud America 402
AF - Africa 168
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.092
Nazione #
US - Stati Uniti d'America 7.140
RU - Federazione Russa 1.174
GB - Regno Unito 1.074
IT - Italia 1.064
SG - Singapore 880
CN - Cina 853
IE - Irlanda 692
BR - Brasile 332
VN - Vietnam 324
SE - Svezia 323
HK - Hong Kong 250
FR - Francia 244
UA - Ucraina 242
DE - Germania 212
FI - Finlandia 167
KR - Corea 120
IN - India 97
ZA - Sudafrica 95
ES - Italia 81
BE - Belgio 51
NL - Olanda 51
PK - Pakistan 39
TR - Turchia 37
BD - Bangladesh 35
CA - Canada 33
MX - Messico 31
PL - Polonia 25
JP - Giappone 24
IQ - Iraq 22
AU - Australia 20
AR - Argentina 17
AT - Austria 17
NG - Nigeria 17
CZ - Repubblica Ceca 16
VE - Venezuela 14
IR - Iran 12
SA - Arabia Saudita 12
JO - Giordania 11
MA - Marocco 11
CI - Costa d'Avorio 10
EC - Ecuador 10
EG - Egitto 10
GR - Grecia 10
LT - Lituania 10
KE - Kenya 9
IL - Israele 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
CO - Colombia 6
CH - Svizzera 5
DZ - Algeria 5
KG - Kirghizistan 5
RO - Romania 5
BY - Bielorussia 4
DK - Danimarca 4
LU - Lussemburgo 4
MY - Malesia 4
PE - Perù 4
PH - Filippine 4
PT - Portogallo 4
PY - Paraguay 4
UY - Uruguay 4
UZ - Uzbekistan 4
BO - Bolivia 3
ET - Etiopia 3
HU - Ungheria 3
ID - Indonesia 3
JM - Giamaica 3
LV - Lettonia 3
SN - Senegal 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
CR - Costa Rica 2
EE - Estonia 2
IM - Isola di Man 2
LB - Libano 2
MD - Moldavia 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
BN - Brunei Darussalam 1
BW - Botswana 1
CY - Cipro 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
Totale 16.077
Città #
Dallas 1.761
Southend 930
Dublin 685
Fairfield 674
Ashburn 576
Singapore 502
Moscow 331
Santa Clara 320
Chandler 318
Woodbridge 274
Siena 269
Houston 263
Beijing 238
Hong Kong 237
Cambridge 228
San Jose 223
Wilmington 208
Seattle 201
Jacksonville 187
Hefei 162
Ann Arbor 153
Council Bluffs 137
New York 126
Seoul 116
The Dalles 113
Los Angeles 103
Princeton 100
Helsinki 95
Johannesburg 90
Florence 88
Ho Chi Minh City 86
Milan 85
Lauterbourg 82
Nanjing 76
Munich 65
Dong Ket 64
Hanoi 58
Málaga 51
Shanghai 47
Rome 41
San Diego 38
Boardman 33
Buffalo 32
São Paulo 32
London 29
San Mateo 28
Frankfurt am Main 27
Orem 26
Turku 26
Brussels 23
Chicago 22
Columbus 22
Warsaw 22
Chennai 21
Nuremberg 21
Bengaluru 20
Dearborn 19
Redondo Beach 19
Washington 19
Da Nang 18
Fremont 18
Nanchang 18
Phoenix 18
Lappeenranta 17
Leuven 16
Abuja 15
Changsha 14
Düsseldorf 14
Montreal 14
Tokyo 14
Zhengzhou 14
Amsterdam 13
Brooklyn 13
Mumbai 13
Portsmouth 13
Atlanta 12
Brno 12
Dhaka 12
Izmir 12
Karachi 12
Lahore 12
Manchester 12
Pisa 12
Amman 11
Jiaxing 11
Redwood City 11
Verona 11
Abidjan 10
Biên Hòa 10
Denver 10
Hebei 10
Redmond 10
San Francisco 10
Toronto 10
Vienna 10
Baghdad 9
City of London 9
Falls Church 9
Haiphong 9
Istanbul 9
Totale 11.349
Nome #
Comprehensive sequencing profile and functional analysis of IsomiRs in human pancreatic islets and beta cells 1.231
MicroRNA expression in the aqueous humor of patients with diabetic macular edema 322
Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes 304
Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging? 303
G-protein coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives 297
From immunohistological to anatomical alterations of human pancreas in type 1 diabetes: New concepts on the stage 293
Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells 292
MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes 291
Lymphocyte-derived exosomal microRNAs promote pancreatic β-cell death and may contribute to type 1 diabetes development. 287
Circulating microRNA (miRNA) expression profiling in plasma of patients with gestational diabetes mellitus reveals upregulation of miRNA miR-330-3p 279
miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes 279
Circulating MicroRNAs as biomarkers of gestational diabetes mellitus: Updates and perspectives 278
Serum Levels of miR-148a and miR-21-5p Are Increased in Type 1 Diabetic Patients and Correlated with Markers of Bone Strength and Metabolism 277
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population. 275
Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression 268
MicroRNA expression analysis of in vitro dedifferentiated human pancreatic islet cells reveals the activation of the pluripotency-related microRNA cluster miR-302s 266
MicroRNA miR-124a, a negative regulator of insulin secretion, is hyperexpressed in human pancreatic islets of type 2 diabetic patients 261
Islet-reactive CD8+T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors 254
MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells 253
Conventional and Neo-Antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors 245
Prognostic bioindicators in severe COVID-19 patients 244
MicroRNA profiling in sera of patients with type 2 diabetes mellitus reveals an upregulation of miR-31 expression in subjects with microvascular complications 237
Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes 237
Delta-cell specific expression of Hedgehog pathway Ptch1 receptor in murine and human endocrine pancreas 236
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets 235
MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p regulate the expression of proapoptotic bh3-only proteins DP5 and PUMA in human pancreatic β-cells 223
Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells 221
A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of individuals with recent-onset type 1 diabetes 220
The Landscape of microRNAs in βCell: between phenotype maintenance and protection 217
Prevention and treatment of autoimmune diseases with plant virus nanoparticles 217
MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion 214
Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes 210
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes 209
Coxsackieviruses and Insulitis 206
A three-layer perspective on miRNA regulation in β cell inflammation 200
Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside 200
Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10-Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells 200
Angiotensin I-converting enzyme type 2 expression is increased in pancreatic islets of type 2 diabetic donors 198
Non-coding RNAs: novel players in insulin resistance and related diseases 197
Oral delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. 196
Multi-Omics Integrative Approach of Extracellular Vesicles: A Future Challenging Milestone 194
Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes 190
MicroRNA circolanti come biomarcatori per il diabete mellito di tipo 2: avanzamenti e prospettive future 189
Circulating microRNAs signature for predicting response to GLP1-RA therapy in Type 2 diabetic patients: a pilot study 187
Serum Proteomic Profile of Asthmatic Patients after Six Months of Benralizumab and Mepolizumab Treatment 187
Increased Expression of Viral Sensor MDA5 in Pancreatic Islets and in Hormone-Negative Endocrine Cells in Recent Onset Type 1 Diabetic Donors 186
Viral Infections and diabetes 183
A plasma miR-193b-365 signature combined with age and glycemic status predicts response to Lactococcus lactis-based antigen-specific immunotherapy in new-onset type 1 diabetes 181
MicroRNAs as new tools for exploring type 1 diabetes: relevance for immunomodulation and transplantation therapy 179
SARS-CoV-2 receptor Angiotensin I-Converting Enzyme type 2 (ACE2) is expressed in human pancreatic β-cells and in the human pancreas microvasculature 178
Enteroviral Infections and Development of Type 1 Diabetes: The Brothers Karamazov Within the CVBs 178
The case for virus-induced type 1 diabetes 177
Dietary supplementation with high doses of regular vitamin D3 safely reduces Diabetes incidence in nod mice when given early and long-term. 177
Virus infections: lessons from pancreas histology 176
Reduced miR-184-3p expression protects pancreatic β-cells from lipotoxic and proinflammatory apoptosis in type 2 diabetes via CRTC1 upregulation 170
Microbioma intestinale e diabete mellito 170
Common molecular pathways targeted by nintedanib in cancer and IPF: a bioinformatic study 169
Immunology in the clinic review series; focus on type 1 diabetes and viruses: how viral infections modulate beta cell function 164
Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity 162
Protocol to analyze circulating small non-coding RNAs by high-throughput RNA sequencing from human plasma samples 139
Extracellular vesicles in immune system regulation and Type 1 diabetes: cell-to-cell communication Mediators, disease biomarkers, and promising therapeutic tools 134
Identification and Validation of miR-222-3p and miR-409-3p as Plasma Biomarkers in Gestational Diabetes Mellitus Sharing Validated Target Genes Involved in Metabolic Homeostasis 132
null 128
Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasis 127
CD8+ T Cells Variably Recognize Native Versus Citrullinated GRP78 Epitopes in Type 1 Diabetes 125
NF-κB-inducing kinase (NIK) is activated in pancreatic β-cells but does not contribute to the development of diabetes 125
Micro-RNA expression profiling in Paget's disease of bone 122
MicroRNAs: Novel players in the dialogue between pancreatic islets and immune system in autoimmune diabetes 122
Immunoregulated insulitis and slow-progressing type 1 diabetes after duodenopancreatectomy 112
Multi‐omics analysis reveals drivers of loss of β‐cell function after newly diagnosed autoimmune type 1 diabetes: An INNODIA multicenter study 111
Maternal gluten, cereal, and dietary fiber intake during pregnancy and lactation and the risk of islet autoimmunity and type 1 diabetes in the child 111
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells 110
null 106
Intestinal Delivery of Proinsulin and IL-10 via Lactococcus lactis Combined With Low-Dose Anti-CD3 Restores Tolerance Outside the Window of Acute Type 1 Diabetes Diagnosis 105
null 90
Coxsackie-adenovirus receptor expression is enhanced in pancreas from patients with type 1 diabetes 79
null 79
Human induced pluripotent stem cells differentiate into insulin-producing cells able to engraft in vivo 65
Totale 16.391
Categoria #
all - tutte 46.432
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.432


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021355 0 0 0 0 0 0 0 0 0 151 91 113
2021/2022913 72 131 61 100 39 31 39 30 38 78 113 181
2022/20231.318 72 133 134 158 140 281 31 85 108 66 62 48
2023/20241.243 39 49 111 74 58 340 375 39 6 62 15 75
2024/20252.415 49 128 276 148 314 153 108 138 230 111 229 531
2025/20266.177 429 696 1.674 685 1.091 185 668 204 237 308 0 0
Totale 16.391